Why This Massachusetts Synthetic Bio Startup Could be the Next Biotech Unicorn Post author:Sam Post published:December 11, 2017 Post category:BioPharma In investment jargon, a “unicorn” has at least two meanings. Source: BioSpace You Might Also Like Johnson & Johnson's Animas to Shut Down Ops and Exit Insulin Pump Biz, 410 Jobs Affected October 4, 2017 FDA Greenlights New Treatment for Multi-Drug Resistant HIV-1 March 6, 2018 Epinex Diagnostics To Present At The BIO CEO & Investor Conference February 9, 2017
Johnson & Johnson's Animas to Shut Down Ops and Exit Insulin Pump Biz, 410 Jobs Affected October 4, 2017
